세계
진보 성향
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
The Guardian World
조회 0
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older
US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic.
Moderna is seeking Food and Drug Administration (FDA) approval of its new shot , dubbed mFlusiva, as an option for people 50 and older. The FDA advisory committee meeting is a step toward a final decision ahead of the winter flu season.
Continue reading...
이 뉴스, 독자들은 어떻게 느꼈나요?
첫 반응을 남겨보세요로그인하면 감정 반응에 참여할 수 있어요.
공식 발표 ↔ 진영별 보도
진보 성향 33%중도 성향 67%
1건2건
보수 성향 매체엔 안 보이는 이슈
공식 발표 (3건) — 공공 라이선스 원문 직접 열람
진보 성향1
중도 성향2
보수 성향0
보도 없음
관련 뉴스 제보는 로그인 후 가능합니다.
'world' 카테고리 뉴스
The Guardian의 다른 기사
The CGT ‘backflip’ is more tweak than transformation. Labor hasn’t changed its mind on housing
The Guardian World
Australian net overseas migration falls to lowest level since 2022 – but the Coalition says that’s still too high
The Guardian World
Wiltshire village exhibits Martin Parr’s final photos of scarecrows and prize veg
The Guardian World